- Home
- OSUR vs LIEN Comparison
OSUR vs LIEN Comparison
Compare OSUR & LIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- LIEN
- Stock Information
- Founded
- OSUR 2000
- LIEN 2021
- Country
- OSUR United States
- LIEN United States
- Employees
- OSUR N/A
- LIEN N/A
- Industry
- OSUR Medical/Dental Instruments
- LIEN
- Sector
- OSUR Health Care
- LIEN
- Exchange
- OSUR Nasdaq
- LIEN NYSE
- Market Cap
- OSUR 223.0M
- LIEN 234.6M
- IPO Year
- OSUR 1986
- LIEN 2022
- Fundamental
- Price
- OSUR $3.10
- LIEN $10.75
- Analyst Decision
- OSUR Hold
- LIEN Buy
- Analyst Count
- OSUR 1
- LIEN 2
- Target Price
- OSUR $3.00
- LIEN N/A
- AVG Volume (30 Days)
- OSUR 750.0K
- LIEN 61.1K
- Earning Date
- OSUR 08-05-2025
- LIEN 08-07-2025
- Dividend Yield
- OSUR N/A
- LIEN 12.66%
- EPS Growth
- OSUR N/A
- LIEN 30.25
- EPS
- OSUR N/A
- LIEN 1.15
- Revenue
- OSUR $161,626,000.00
- LIEN $30,828,508.00
- Revenue This Year
- OSUR N/A
- LIEN $154.46
- Revenue Next Year
- OSUR $6.20
- LIEN $10.64
- P/E Ratio
- OSUR N/A
- LIEN $9.31
- Revenue Growth
- OSUR N/A
- LIEN 151.96
- 52 Week Low
- OSUR $2.36
- LIEN $9.70
- 52 Week High
- OSUR $4.92
- LIEN $13.38
- Technical
- Relative Strength Index (RSI)
- OSUR 59.68
- LIEN N/A
- Support Level
- OSUR $3.00
- LIEN N/A
- Resistance Level
- OSUR $3.13
- LIEN N/A
- Average True Range (ATR)
- OSUR 0.12
- LIEN 0.00
- MACD
- OSUR 0.00
- LIEN 0.00
- Stochastic Oscillator
- OSUR 80.65
- LIEN 0.00
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company is an externally managed, closed-end, non-diversified management investment company with an investment objective to maximize risk-adjusted returns on equity for its stockholders by investing in direct loans to privately held middle-market companies, with a focus on cannabis companies.